Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ALKS · against 177 other Healthcare companies of similar size
Ranked #163 of 178 · scores higher than 8% of peers
Bars: peers in each 10-point band of the growth score11 peers with a growth score of 20–29, including ALKS · Click a bar to see the companies
Mainly because of its earnings per share growth, which is weaker than most Healthcare peers.
| Metric | ALKS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 179 reported | 10.8% | 10.2% | 51% | 33% | |
| Earnings per share growthHigher is better · 125 reported | -81.3% | 14.9% | 3% | 33% | |
| 3-year revenue growthHigher is better · 173 reported | 4.5% | 10.5% | 24% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 2 | 9.3B USD | 98 | 64 | |
| 4 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 4 | 4.0B USD | 97 | 56 | |
| 158 | 11.9B USD | 28 | 53 | |
| 160 | 12.7B AUD (≈$8.4B) | 27 | 38 | |
| 161 | 1.85T JPY (≈$12.5B) | 26 | 55 | |
| 162 | 10.0B USD | 25 | 43 | |
| 163 | 7.7B USD | 24 | 37 | |
| 163 | 5.5B USD | 24 | 43 | |
| 165 | 35.1B CNY (≈$4.9B) | 23 | 56 | |
| 165 | 4.0B EUR (≈$4.4B) | 23 | 49 | |
| 167 | 9.3B AUD (≈$6.1B) | 21 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score